Brazil Self-Monitoring Blood Glucose Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The Brazilian self-monitoring blood glucose devices market is segmented into components (glucometer devices, test strips, and lancets). The report offers the value (in USD million) and volume (in units million) for the above segments.

Brazil Self-Monitoring Blood Glucose Devices Market Size

Brazil Self-Monitoring Blood Glucose Devices Market Summary
share button
Study Period 2017-2028
Base Year For Estimation 2022
Forecast Data Period 2023 - 2028
Historical Data Period 2018 - 2021
CAGR 4.60 %

Major Players

Brazil Self-Monitoring Blood Glucose Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Brazil Self-Monitoring Blood Glucose Devices Market Analysis

The Brazil self-monitoring blood glucose devices market is expected to register a CAGR of 4.6% and reach a value of about USD 429 million over the forecast period.

During the COVID-19 pandemic, patients with diabetes were at higher risk for hospitalizations and complications due to hyper- or hypoglycemia, metabolic comorbidities, and more severe illness from the SARS-CoV-2 infection. Maintaining euglycemia was important to decrease morbidity and mortality in the hospital setting. According to experts, inpatient use of diabetes technology in patients with proper institutional protocols was safe, improved inpatient glycemic outcomes, and played a vital role in managing hypoglycemia and hyperglycemia in hospitalized patients.

Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. The measurement of blood glucose helps in determining the effectiveness of blood glucose metabolism and guides in achieving optimal glucose control within the body. Over time, the readings provide the patient and their health professionals with the information required to determine the best management strategy for diabetes. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.

Technological advancements in blood glucose meters, including cellular-connected devices that automatically upload SMBG data to secure cloud-based databases, allow for improved sharing and monitoring of SMBG data. Real-time monitoring of SMBG data presents opportunities to provide timely support to patients who are responsive to abnormal SMBG recordings. Such advantages can provide patients with poorly controlled T2D with the additional support needed to improve critical outcomes, thereby enhancing the market's prospects in the years to come.

Brazil Self-Monitoring Blood Glucose Devices Industry Segmentation

Self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood sugar level themselves using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The Brazil self-monitoring blood glucose device market is segmented into components (glucometer devices, test strips, and lancets). The report offers the value (in USD million) and volume (in units million) for the above segments.

Glucometer Devices
Test Strips

Report scope can be customized per your requirements. Click here.

Brazil Self-Monitoring Blood Glucose Devices Market Trends

Rising Diabetes Prevalence in Brazil

The diabetes population in Brazil is expected to grow by about 2.9% over the forecast period.

According to the IDF Diabetes Atlas 2021, 15.7 million adults, or 10.5%, were living with diabetes in Brazil. The cost of diabetes-related health expenditures in Brazil is the third-highest in the world. In addition, 18 million adults (around 11.9%) have impaired glucose tolerance, which places them at high risk of developing type-2 diabetes. 32% of people living with diabetes in Brazil are undiagnosed. Additional data on glycemic control in Brazil show that only 25% met the therapeutic goal of glycated hemoglobin (HbA1c) < 7% before the pandemic, as recommended by the Brazilian Diabetes Society (SBD).

In Brazil, the public health system (Sistema Nico de Sade; SUS) has been progressively increasing the assistance available for individuals with diabetes. The Ministry of Health established a list of medications and supplies provided by the Brazilian Health System (SUS) to patients suffering from diabetes. However, their supply is usually not sufficient or recommended for optimal patient management across cities. The high prevalence of diabetes is associated with a significant economic burden.

When diabetes is undetected or inadequately treated, people with diabetes are at risk of serious and life-threatening complications, such as heart attack, stroke, kidney failure, blindness, and lower-limb amputation. These result in reduced quality of life and higher healthcare costs, leading to a greater need for access to care. Various pieces of evidence suggest that diabetes can be successfully managed, especially when detected early. Multifactorial intervention, including control of blood glucose, blood pressure, and lipids, can reduce the broad range of diabetes-related microvascular and macrovascular complications and premature mortality. ​

Therefore, owing to the increasing prevalence of diabetes, the studied market is anticipated to witness growth over the analysis period.

Brazil Self-Monitoring Blood Glucose Devices Market, Diabetes Population (in million), 2017-2022

The Test Strips Segment holds the highest market share in the current year

The test strip segment held the highest market share of about 84% in the current year.

Blood glucose test strips are small, disposable strips and are a key component of blood glucose testing. When blood is placed on the test strip, it reacts with a chemical called glucose oxidase, producing gluconic acid from the glucose in the blood. At the other end of the test strip, the meter transfers a current to the strip. The test strip has electric terminals, which allow the meter to measure the current between the terminals. The current between the terminals changes depending on the level of gluconic acid that has been produced. The blood glucose meter then uses an algorithm to work out the blood glucose level based on the difference in current.

The growth in market share of test strips is expected to be higher than that of glucose meters because of the difference in use-case frequency. The glucometer is a one-time purchase; test strips, on the other hand, are a continuous investment as a test strip needs to be disposed of after one use, causing a recurrent cost impact. While an average glucose meter lasts anywhere between six months and three years, presenting a one-time cost during the same time frame,

Brazil has implemented a set of reforms over the past decade to improve the distribution of doctors, develop new forms of service organization, introduce new financing models, and implement a range of quality improvement initiatives and policy frameworks to overcome risk factors such as obesity and emerging threats. The Federal Government of Brazil partnered with numerous private companies to utilize their supply chain (manufacturing, distribution, and retailers), primarily to ensure low prices.

Thus, the above-mentioned factors are expected to drive the segment’s growth over the forecast period.

Brazil Self-monitoring Blood Glucose Devices Market: Volume CAGR (%), by Component, 2023-2028

Brazil Self-Monitoring Blood Glucose Devices Industry Overview

The Brazil self-monitoring blood glucose device market is moderately fragmented, with few significant and other generic players. Manufacturers like Abbott, LifeScan, Roche, Ascensia, etc. occupy a major share.

Brazil Self-Monitoring Blood Glucose Devices Market Leaders

  1. Roche Diabetes Care

  2. Abbott Diabetes Care

  3. LifeScan

  4. Ascensia Diabetes Care

  5. i-Sens

*Disclaimer: Major Players sorted in no particular order

Brazil Self-Monitoring Blood Glucose Devices Market Concentration

Brazil Self-Monitoring Blood Glucose Devices Market News

  • January 2023: LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology published Improved Glycemic Control Using a Bluetooth Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes – one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.
  • June 2022: LifeScan announced that the peer-reviewed journal Diabetes Technology and Therapeutics published Real World Evidence of Improved Glycemic Control in People with Diabetes using a Bluetooth-connected Blood Glucose Meter with Mobile Diabetes Management Application using the OneTouch Reveal mobile app with the OneTouch Verio Reflect meter- synced via Bluetooth wireless technology could support improved glycemic control for people with diabetes.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 Component

      1. 5.1.1 Glucometer Devices

      2. 5.1.2 Test Strips

      3. 5.1.3 Lancets


    1. 6.1 Type-1 Diabetes population

    2. 6.2 Type-2 Diabetes population



      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 Roche Diabetes Care

      3. 7.1.3 LifeScan

      4. 7.1.4 Ascensia Diabetes Care

      5. 7.1.5 Menarini

      6. 7.1.6 i-Sens

      7. 7.1.7 Arkray Inc.

    2. *List Not Exhaustive

      1. 7.2.1 Abbott Diabetes Care

      2. 7.2.2 Roche Diabetes Care

      3. 7.2.3 LifeScan

      4. 7.2.4 Other Company Share Analyses


**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Brazil Self-Monitoring Blood Glucose Devices Market is projected to register a CAGR of 4.6% during the forecast period (2023-2028).

Roche Diabetes Care, Abbott Diabetes Care, LifeScan, Ascensia Diabetes Care and i-Sens are the major companies operating in the Brazil Self-Monitoring Blood Glucose Devices Market.

Brazil Self-Monitoring Blood Glucose Devices Industry Report

Statistics for the 2023 Brazil Self-Monitoring Blood Glucose Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Brazil Self-Monitoring Blood Glucose Devices analysis includes a market forecast outlook to for 2023 to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!